Publisher's Synopsis
The struggle to improve long-term disease-free survival and to reduce mortality in patients with operable breast cancer remains one of the most controversial issues in clinical oncology world-wide. This volume summarizes the most recent medium- to long-term results of clinical trials in adjuvant chemo-, hormono- and radiotherapy in Europe and North